Title: Latin American registry of Waldenstroms Disease

Primary Objetive is to obtain real-world data of WM in Latin America, describing characteristics of patients at diagnosis, access to diagnostic tests, drug affordability, practice patterns of treatment and outcomes.

Principal Investigator: Dra. Eloísa Riva (Uruguay)

e-mail: [email protected]


Title: Epidemiology and risk factors for the development of infections in patients with Multiple Myeloma: a multicenter study in Latin America

Primary objective is to know the epidemiology of infections prevalence, site, germs, treatment and evolution) and to identify risk factors for their development in patients with Active Multiple Myeloma in the first 6 months of their diagnosis.

Principal Investigator: Virginia Bove, Eloisa Riva (Uruguay)

e-mail: [email protected], [email protected]


Title: Epidemiological study on primary plasma cell leukemia in Latin America

Primary objective it is the epidemiological and laboratory characteristics of patients with PCLp in LATAM

Principal Investigator: Camila Peña

email: [email protected]


Title: Latin American Registry of Amyloidosis

Primary objective is to know the epidemiology of diagnosed amyloidosis in Latin America

Principal Investigator: Eloisa Riva (Uruguay)

email: [email protected]


Title: Evaluation of the cytogenetic and cytomolecular characteristics of patients with Multiple Myeloma in Latin America

Primary objective is to describe the genetic alterations of Latin American patients with MM and to establish risk groups

Principal Investigator: Paola Leone, Flavia Stella, Irma Slavutsky

e-mail: [email protected], [email protected], [email protected]


Title: Multicenter prospective observational study of patients diagnosed with multiple myeloma and COVID-19 infection

Primary Objetive is to provide epidemiological data on patients diagnosed with MM and COVID-19 infection.

Principal investigator: Humberto Martínez-Cordero, Alana Seisha Von Glasenapp, Aline G Ramírez-Alvarado

e-mail: [email protected], [email protected], [email protected]